NASDAQ: AKBA

Analyst Snapshot

Analyzing AKBA’s price-to-book ratio for the last quarter

Kenneth Phillips

Currently, Akebia Therapeutics Inc’s (AKBA) stock is trading at $1.39, marking a gain of 1.00% from last night’s close. At ...

Market Summary

AKBA stock’s current quarter earnings estimates: What analysts predict?

Arcelia Reed

As of this writing, shares are priced at -60.28% less than their 52-week high of $4.08, and 12.11% over their ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.